(-0.34%) 5 031.75 points
(-0.30%) 37 894 points
(-0.57%) 17 447 points
(0.50%) $83.14
(-0.80%) $1.743
(-0.02%) $2 397.60
(0.05%) $28.40
(-0.47%) $950.00
(-0.14%) $0.938
(-0.11%) $11.03
(-0.12%) $0.803
(-0.64%) $93.30
-2.00% ¥ 1 175.00
Live Chart Being Loaded With Signals
Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc...
Stats | |
---|---|
Today's Volume | 68 800.00 |
Average Volume | 77 142.00 |
Market Cap | 58.98B |
EPS | ¥0 ( 2024-02-06 ) |
Next earnings date | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥27.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 8.09 |
ATR14 | ¥1.148 (0.10%) |
Volume Correlation
Vital KSK Holdings, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vital KSK Holdings, Inc. Correlation - Currency/Commodity
Vital KSK Holdings, Inc. Financials
Annual | 2022 |
Revenue: | ¥579.77B |
Gross Profit: | ¥44.96B (7.76 %) |
EPS: | ¥92.69 |
Q3 | 2023 |
Revenue: | ¥154.70B |
Gross Profit: | ¥12.79B (8.26 %) |
EPS: | ¥53.93 |
Q2 | 2023 |
Revenue: | ¥149.67B |
Gross Profit: | ¥12.12B (8.10 %) |
EPS: | ¥28.03 |
Q1 | 2023 |
Revenue: | ¥144.54B |
Gross Profit: | ¥11.46B (7.93 %) |
EPS: | ¥17.79 |
Financial Reports:
No articles found.
Vital KSK Holdings, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥12.00 (N/A) |
¥0 (N/A) |
¥27.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥10.80 | 2010-03-29 |
Last Dividend | ¥27.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 28 | -- |
Total Paid Out | ¥252.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.22 | -- |
Div. Sustainability Score | 8.77 | |
Div.Growth Potential Score | 4.17 | |
Div. Directional Score | 6.47 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
7972.T | Ex Dividend Knight | 2023-12-28 | Annually | 0 | 0.00% | |
7211.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
6457.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5463.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4452.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
3641.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
2897.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
1716.T | Ex Dividend Knight | 2024-06-27 | Annually | 0 | 0.00% | |
9759.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
8830.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0127 | 1.500 | 9.75 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0227 | 1.200 | 9.24 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0740 | 1.500 | -0.289 | -0.434 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.040 | 0.800 | 9.80 | 7.84 | [1 - 3] |
quickRatioTTM | 0.863 | 0.800 | 9.63 | 7.70 | [0.8 - 2.5] |
cashRatioTTM | 0.150 | 1.500 | -0.277 | -0.416 | [0.2 - 2] |
debtRatioTTM | 0.0244 | -1.500 | 9.59 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 65.23 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 129.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 129.97 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0790 | -1.500 | 9.68 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0811 | 1.000 | -1.981 | -1.981 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0107 | 1.000 | -1.786 | -1.786 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.814 | 1.000 | 6.59 | 6.59 | [0.2 - 2] |
assetTurnoverTTM | 1.783 | 0.800 | 1.446 | 1.156 | [0.5 - 2] |
Total Score | 8.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 8.14 | 1.000 | 9.28 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0740 | 2.50 | -0.186 | -0.434 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 129.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.39 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 129.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.487 | 1.500 | 3.42 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0111 | 1.000 | -2.22 | 0 | [0.1 - 0.5] |
Total Score | 4.17 |
Vital KSK Holdings, Inc.
Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators